- Global Pharma News & Resources

The spending on Clinical Trials is projected to grow at ~4% CAGR through 2029

Collaboration at Its Peak: Key Strategy of Manufacturers in Clinical Trials Market

For reducing economic burden, many companies are planning to shift their focus towards on-core business activities, thereby outsourcing their clinical trials activities to the CROs (contract research organizations). This in turn influences biotechnology and pharmaceutical companies for outsourcing clinical trials activities to the CROs in APAC. Major CROs are approached by the drug companies at a notable rate for close business collaboration, which in turn results in increasing number of consolidations by means of M7A in CRO industry.

  • Eli Lilly and Company:The clinical trials company has made an announcement regarding its collaboration with NextCure, Inc. for discovering and developing immuno-oncology therapies. This collaboration will mainly help in discovering new cancer targets using proprietary FIND-IO platform of NextCure, Inc. This in turn is likely to create ample growth opportunities for clinical trials market with increasing number of research activities probable to take place.
  • Novo Nordisk A/S:The clinical trials company recently entered into a research collaboration with Embark Biotech ApS for discovering new treatments beneficial for obesity and its related metabolic pathologies by means of mechanisms, which increase energy expenditure. Clinical trials market is likely to witness major revenue contribution from the emerging development of the next-gen anti-obesity therapies by Novo Nordisk A/S and Embark Biotech ApS.
  • Sanofi Aventis A.S.:The clinical trials company lately introduced Aubagio®, which is a once-a-day oral medicine that is highly effective and convenient for Multiple Sclerosis diagnosed patients. Better diagnostic facilities and growing awareness is leading to new cases of Multiple Sclerosis. This proven clinical-efficiency can be taken up as a long-term treatment with safe and tolerable outcomes, thereby stimulating the need for further clinical trials.

Get Report Sample @

India to Take a Major Toll in Clinical Trials Market

Developing economies such as India clinical trials market is expected to prove attractive markets owing to increasing availability of expert practitioners, growing government support with regards to development of the outsourcing hubs. Growing prevalence of metabolic disorders with rising number of patients suffering from obesity, metabolic disorders and are insulin resistant continues to offer growth opportunities for APAC clinical trials market. Lesser insurance coverage and growing medical expenses due to increasing presence of private hospitals is leading to rapidly increasing need for clinical trials for accessing free-of-cost high-quality healthcare. Reduced labor cost for the clinical operations personnel, lower recruitment costs, low costs related to handling of clinical trial supplies and growing focus on multiple orphan drugs further drives the growth of APAC clinical trials market.

Biopharmaceutical Companies to Significantly Drive Revenue Growth of Clinical Trials Market

Virtual development models are expected to provide new pathways for the clinical trials market in the near future with surging demand from the pharmaceutical companies. Introduction of new medications such as personalized medicine and growing demand for CROs for conducting clinical trials is expected to drive clinical trials market across the globe. Growing number of patients suffering from special diseases offers biopharmaceutical companies manufacturing opportunities, which in turn leads them to make heavy investments in clinical trials. Dearth of experts for the purpose of operating innovative and advanced CTMS solutions is likely to pose significant challenges for the clinical trials market.

Bifurcation of Clinical Trials Market Is Done Based On Indication and Phases

On the basis of indication, clinical trials market is segmented into

  • Mental disorders
  • Gastrointestinal diseases
  • Cardio vascular system (CVS) diseases
  • Metabolic disorders
  • Dermatology
  • Infections
  • Central nervous system (CNS)
  • Musculoskeletal diseases
  • Congenital diseases
  • Genitourinary diseases
  • Cancer
  • Circulatory diseases
  • Autoimmune diseases
  • Ophthalmology
  • Blood disorders
  • Others

On the basis of phases, clinical trials market is segmented into

  • Phase IV
  • Phase III
  • Phase II
  • Phase I

The clinical trials market research report offers comprehensive analysis of the global market and consists of thoughtful insights, historical data and facts along with industry validated and statistically supported market data. In addition, the clinical trials market research report had mentioned forecasted information by means of suitable set of methodologies and assumptions. The report further offers information and analysis based on market segments.

Any Queries, Contact us @

Why Future Market Insights?

  • Comprehensive analysis on evolving purchase pattern across different geographies
  • Detailed insights of market segments and sub-segments for historical as well as forecast period
  • A competitive analysis of prominent players and emerging players in the Radiometric Detectors market
  • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
  • Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.


Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates


For Sales Enquiries:

For Media Enquiries:

Editor Details

Last Updated: 06-Jul-2021